High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study

Similar Items

• The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
  by: Michele Guida, et al.
  Published: (2018-05-01)
• Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis
  by: Celina Bihan, et al.
  Published: (2012-09-01)
• Effects of fotemustine or dacarbasine on a melanoma cell line pretreated with therapeutic proton irradiation
  by: Privitera Giuseppe, et al.
  Published: (2009-04-01)
• Sensitivity of Zebrafish Embryogenesis to Risk of Fotemustine Exposure
  by: Davide Di Paola, et al.
  Published: (2022-03-01)
• Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma.
  by: Ranson, M, et al.
  Published: (2007)